Gilead Sciences Inc (GILD)
65.42
+0.15
(+0.23%)
USD |
NASDAQ |
Apr 26, 16:00
65.40
-0.02
(-0.03%)
After-Hours: 20:00
Gilead Sciences Shares Outstanding: 1.246B for Feb. 16, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 16, 2024 | 1.246B |
December 31, 2023 | 1.246B |
October 31, 2023 | 1.246B |
September 30, 2023 | 1.247B |
July 31, 2023 | 1.246B |
June 30, 2023 | 1.247B |
April 28, 2023 | 1.247B |
March 31, 2023 | 1.248B |
March 15, 2023 | 1.249B |
February 28, 2023 | 1.247B |
February 17, 2023 | 1.247B |
December 31, 2022 | 1.247B |
October 31, 2022 | 1.254B |
September 30, 2022 | 1.254B |
July 29, 2022 | 1.253B |
June 30, 2022 | 1.254B |
April 29, 2022 | 1.254B |
March 31, 2022 | 1.255B |
March 15, 2022 | 1.256B |
February 28, 2022 | 1.253B |
February 18, 2022 | 1.254B |
December 31, 2021 | 1.254B |
October 29, 2021 | 1.254B |
September 30, 2021 | 1.255B |
July 30, 2021 | 1.254B |
Date | Value |
---|---|
June 30, 2021 | 1.254B |
April 30, 2021 | 1.254B |
March 31, 2021 | 1.254B |
March 19, 2021 | 1.259B |
February 26, 2021 | 1.257B |
February 18, 2021 | 1.257B |
December 31, 2020 | 1.254B |
October 30, 2020 | 1.254B |
September 30, 2020 | 1.253B |
July 31, 2020 | 1.254B |
June 30, 2020 | 1.254B |
April 30, 2020 | 1.254B |
March 31, 2020 | 1.254B |
March 13, 2020 | 1.259B |
February 28, 2020 | 1.260B |
February 18, 2020 | 1.264B |
December 31, 2019 | 1.266B |
October 29, 2019 | 1.265B |
September 30, 2019 | 1.266B |
June 30, 2019 | 1.266B |
April 30, 2019 | 1.272B |
March 31, 2019 | 1.274B |
March 15, 2019 | 1.275B |
February 28, 2019 | 1.275B |
February 15, 2019 | 1.276B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.246B
Minimum
Feb 16 2024
1.272B
Maximum
Apr 30 2019
1.254B
Average
1.254B
Median
Mar 31 2020
Shares Outstanding Benchmarks
Amgen Inc | 535.92M |
CymaBay Therapeutics Inc (DELISTED) | 114.78M |
Bristol-Myers Squibb Co | 2.027B |
Eli Lilly and Co | 950.77M |
Merck & Co Inc | 2.533B |